Unlock Premium for Just $9.99/Month – Special Launch Offer, Limited Time Only
Get Premium
BLCO Bausch + Lomb Corp
- Stocks
- Healthcare
- NYSE: BLCO
Price (delayed)
$11.27
Market cap
$3.98B
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$1.03
Enterprise value
$8.6B
Bausch + Lomb is a leading global eye health company dedicated to protecting and enhancing the gift of sight for millions of people around the world—from the moment of birth
Highlights
BLCO's revenue is up by 12% year-on-year
BLCO's gross profit is up by 11% year-on-year
The company's EPS fell by 14% QoQ and by 7% YoY
The net income has declined by 14% since the previous quarter and by 7% year-on-year
Key stats
What are the main financial stats of BLCO
Market
Valuations
Earnings
Shares outstanding
353.4M
Market cap
$3.98B
Enterprise value
$8.6B
Price to earnings (P/E)
N/A
Price to book (P/B)
0.62
Price to sales (P/S)
0.82
EV/EBIT
140.93
EV/EBITDA
17.44
EV/Sales
1.78
Revenue
$4.83B
Gross profit
$2.9B
Operating income
$73M
Net income
-$362M
EBIT
$61M
EBITDA
$493M
Free cash flow
-$168M
Per share
Balance sheet
Liquidity
EPS
-$1.03
EPS diluted
-$1.03
Free cash flow per share
-$0.48
Book value per share
$18.05
Revenue per share
$13.69
TBVPS
$15.4
Total assets
$13.43B
Total liabilities
$7B
Debt
$4.83B
Equity
$6.36B
Working capital
$968M
Debt to equity
0.76
Current ratio
1.56
Quick ratio
0.71
Net debt/EBITDA
9.36
Margins
Efficiency
Dividend
EBITDA margin
10.2%
Gross margin
60%
Net margin
-7.5%
Operating margin
1.5%
Return on assets
-2.7%
Return on equity
-5.6%
Return on invested capital
0.8%
Return on capital employed
0.5%
Return on sales
1.3%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
BLCO stock price
How has the Bausch + Lomb stock price performed over time
Intraday
-2%
1 week
-2%
1 month
-10.06%
1 year
-26.29%
YTD
-37.6%
QTD
-22.28%
Financial performance
How have Bausch + Lomb's revenue and profit performed over time
Revenue
$4.83B
Gross profit
$2.9B
Operating income
$73M
Net income
-$362M
Gross margin
60%
Net margin
-7.5%
The operating margin has dropped by 56% since the previous quarter and by 53% year-on-year
Bausch + Lomb's operating income has shrunk by 55% QoQ and by 47% YoY
The net income has declined by 14% since the previous quarter and by 7% year-on-year
BLCO's net margin is down by 14% since the previous quarter but it is up by 3.8% year-on-year
Price vs fundamentals
How does BLCO's price correlate with its fundamentals
Growth
What is Bausch + Lomb's growth rate over time
Valuation
What is Bausch + Lomb stock price valuation
P/E
N/A
P/B
0.62
P/S
0.82
EV/EBIT
140.93
EV/EBITDA
17.44
EV/Sales
1.78
The company's EPS fell by 14% QoQ and by 7% YoY
The stock's price to book (P/B) is 31% less than its last 4 quarters average of 0.9
The equity has contracted by 4.5% YoY
BLCO's price to sales (P/S) is 32% lower than its last 4 quarters average of 1.2
BLCO's revenue is up by 12% year-on-year
Efficiency
How efficient is Bausch + Lomb business performance
The company's return on sales has shrunk by 59% QoQ and by 52% YoY
The return on invested capital has dropped by 58% since the previous quarter and by 50% year-on-year
Bausch + Lomb's return on equity has decreased by 17% QoQ and by 14% YoY
The return on assets has declined by 13% since the previous quarter and by 3.8% year-on-year
Dividends
What is BLCO's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for BLCO.
Financial health
How did Bausch + Lomb financials performed over time
Bausch + Lomb's total assets is 92% more than its total liabilities
BLCO's current ratio is down by 8% YoY and by 2.5% QoQ
The company's quick ratio fell by 8% QoQ and by 8% YoY
BLCO's debt is 24% smaller than its equity
Bausch + Lomb's debt to equity has increased by 10% YoY and by 2.7% QoQ
BLCO's debt is up by 5% year-on-year
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.